Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Irvine, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Eledon Pharmaceuticals, Inc. has filed 610 SEC EDGAR filings since 18 Jun 2007

SEC filing history

Showing 226-250 of 607 matching filings.

Per page
25
Current page
10
8-K File 001-36620

8-K

Filing date
27 Apr 2021
Reporting date
26 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Apr 2021
Reporting date
19 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-255173

S-8

Filing date
12 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
05 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-254890

S-3

Filing date
31 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
19 Mar 2021
Reporting date
15 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

8-K

Filing date
15 Mar 2021
Reporting date
15 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88334

SC 13G filing

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88334

AMENDMENT NO. 4 TO THE SCHEDULE 13G

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88334

SC 13G/A filing

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88334

SC 13G filing

Filing date
08 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88334

AMENDMENT NO. 8

Filing date
05 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88334

ELEDON PHARMACEUTICALS, INC.

Filing date
04 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88334

SC 13G filing

Filing date
04 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88334

AMENDMENT NO. 3 TO THE SCHEDULE 13G

Filing date
30 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88334

AMENDMENT NO. 2 TO THE SCHEDULE 13G

Filing date
28 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
28 Dec 2020
Reporting date
22 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-251305

EFFECT filing

Filing date
22 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B2 File 333-251305

424B2

Filing date
22 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
17 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
16 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .